Evidence map›Paper›PMID 23816635›Full record

ArticleJournal of innate immunity2014

The role of innate immunity in promoting SaeR/S-mediated virulence in Staphylococcus aureus.

Oliwia W Zurek, Tyler K Nygaard, Robert L Watkins, Kyler B Pallister, Victor J Torres, Alexander R Horswill, Jovanka M Voyich

Open access · bronzeAbstract read
In one paragraph

Article in Journal of innate immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 51 citations in OpenAlex.

  1. GrowingInfection and immunity · 2026
    Article
  2. Article
  3. Article
  4. bioRxiv : the preprint server for biology · 2025
    Article
  5. Linking Virulence and Iron Limitation Response inJournal of proteome research · 2025
    Article
  6. Lung surfactant reducesMicrobiology spectrum · 2025
    Article
  7. Article
  8. Repurposing Diflunisal as an Antivirulence Agent AgainstInfectious microbes & diseases · 2025
    Article
  9. Article
  10. Article
  11. Infection and immunity · 2024
    Article
  12. SaeR as a novel target for antivirulence therapy againstEmerging microbes & infections · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Frontiers in immunology · 2021
    Article
  18. The Accessory GeneFrontiers in microbiology · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Oliwia W ZurekDepartment of Immunology and Infectious Diseases, Montana State University, Bozeman, Mont., USA.
Tyler K Nygaard
Robert L Watkins
Kyler B Pallister
Victor J Torres
Alexander R Horswill
Jovanka M Voyich
Montana State University · USNew York University · USUniversity of Iowa · US

Funding

MT INBRE RESEARCH COREP20RR016455 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI HELD, SUZANNE EILEEN · 2001 to 2011
$34.4M
The S. aureus biofilm lifecycleP01AI083211 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KIELIAN, TAMMY L · 2009 to 2023
$32.1M
VIRUSES: FROM PARTICLES TO PROTEOMICSP20RR020185 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2004 to 2011
$17.0M
Pilot Grants ProgramP30GM110732 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2014 to 2018
$5.4M
Role of the Staphylococcus aureus SaeR/S Regulatory System in Neutrophil EvasionR01AI090046 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI VOYICH, JOVANKA M · 2011 to 2015
$1.7M
Functional Analysis of Staphylococcus aureus LukAB Cytotoxin.R56AI091856 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TORRES, VICTOR J. · 2011 to 2011
$524k
The Role of SaeR/S During Staphylococcus aureus Skin InfectionsR21AI088041 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI VOYICH, JOVANKA M · 2011 to 2012
$392k
NCRR NIH HHS P20 RR016455NCRR NIH HHS P20 RR020185NCRR NIH HHS P20RR16455-07NCRR NIH HHS RR020185NIAID NIH HHS AI083211NIAID NIH HHS P01 AI083211NIAID NIH HHS R01 AI090046NIAID NIH HHS R21 AI088041NIAID NIH HHS R56 AI091856NIAID NIH HHS R56-AI091856-01A1NIGMS NIH HHS P30 GM110732PHS HHS R01 A1090046-01PHS HHS R21 A1088041-01
6 · The paper itself

Abstract

The ability of Staphylococcus aureus to infect tissues is dependent on precise control of virulence through gene-regulatory systems. While the SaeR/S two-component system has been shown to be a major regulator of S. aureus virulence, the influence of the host environment on SaeR/S-regulated genes (saeR/S targets) remains incompletely defined. Using QuantiGene 2.0 transcriptional assays, we examined expression of genes with the SaeR binding site in USA300 exposed to human and mouse neutrophils and host-derived peptides and during subcutaneous skin infection. We found that only some of the saeR/S targets, as opposed to the entire SaeR/S virulon, were activated within 5 and 10 min of interacting with human neutrophils as well as α-defensin. Furthermore, mouse neutrophils promoted transcription of saeR/S targets despite lacking α-defensin, and the murine skin environment elicited a distinctive expression profile of saeR/S targets. These findings indicate that saeR/S-mediated transcription is unique to and dependent on specific host stimuli. By using isogenic USA300ΔsaeR/S and USA300Δagr knockout strains, we also determined that SaeR/S is the major regulator of virulence factors, while Agr, a quorum-sensing two-component system, has moderate influence on transcription of the saeR/S targets under the tested physiological conditions.

Indexed as

alpha-DefensinsAnimalsBacterial ProteinsGene Expression Regulation, BacterialGene Knockout TechniquesHost-Pathogen InteractionsHost SpecificityHumansImmunity, InnateMiceMicroarray AnalysisNeutrophilsSkinStaphylococcal InfectionsStaphylococcus aureusTrans-ActivatorsAgr protein, Staphylococcus aureusalpha-DefensinsBacterial ProteinsSaeR protein, Staphylococcus aureusTrans-ActivatorsTranscription Factors

Identifiers

PMID23816635
PMCPMC4435966
OpenAlexW2004452827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.